FALBERG KATHRYN E — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

FALBERG KATHRYN E has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $4.66M.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-12RCUSArcus Biosciences, Inc.A — Grant or award5.7K$0.00
2026-03-26TTDTrade Desk, Inc.D — Derivative transaction212$59.17$13K
2026-03-26TTDTrade Desk, Inc.D — Derivative transaction296$59.17$18K
2026-03-26TTDTrade Desk, Inc.D — Derivative transaction212$59.17$13K
2026-03-26TTDTrade Desk, Inc.D — Derivative transaction1.2K$0.00
2026-03-09TTDTrade Desk, Inc.S — Open-market sale50.0K$30.48$1.52M
2026-03-09TTDTrade Desk, Inc.S — Open-market sale102.8K$30.45$3.13M
2025-06-10RCUSArcus Biosciences, Inc.A — Grant or award13.3K$0.00
2025-05-27TTDTrade Desk, Inc.A — Grant or award845$59.17$50K
2025-05-27TTDTrade Desk, Inc.A — Grant or award1.2K$59.17$70K
2025-05-27TTDTrade Desk, Inc.A — Grant or award845$59.17$50K
2025-05-27TTDTrade Desk, Inc.A — Grant or award4.9K$0.00
2025-04-15TTDTrade Desk, Inc.A — Grant or award90$63.73$6K

Companies — Last 90 Days

Frequently Asked Questions

Who is FALBERG KATHRYN E?

FALBERG KATHRYN E is a corporate insider — currently tracked as Director of Arcus Biosciences, Inc. (RCUS). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has FALBERG KATHRYN E submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Has FALBERG KATHRYN E been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($4.66M) across all tracked filings.

Where can I see all of FALBERG KATHRYN E's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live FALBERG KATHRYN E profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.